A. Mathias

Discipline

Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Co-auteur

R. Du Pasquier

M. Canales

M. Schluep

C. Pot

S. Perriot

G. Perriard

M. Théaudin

J. Kuhle

C. Fenwick

B. Engelhardt

R.A. Du Pasquier

P.G. Ziros

V. Zimmer

M. Weigel

F. Vuilleumier

V. van Pesch

F. van der Meer

G. Vachey

G.P. Sykiotis

M. Suffiotti

C. Stadelmann

S. Soldati

J. Smolders

E.V. Shusta

F. Shimizu

J.D. Seebach

N. Schaeren-Wiemers

S. Schädelin

P. Sati

Y. Sano

A.W. Sailer

L. Rolf

C. Ribi

M. Rey

C.O. Renaud

D.S. Reich

S. Ramagopalan

R. Rahmanzadeh

C. Pythoud

G. Perrotta

A.L. Perrier

L. Pellerin

V. Pantazou

S.P. Palecek

L. Oberholster

H. Nishihara

A.H. Muris

M. Moulin

C Meunier

N. Merienne

A. Maulet

M. Makhmutova

P. Maggi

P.J. Lu

D. Leppert

F. La Rosa

I. Koneczny

L. Kappos

T. Kanda

S. Jones

R. Hupperts

M. Humbel

A. Horisberger

L. Herrgott

C. Granziera

F. Gosselet

M. Gentner

C. Gaubicher

B.D. Gastfriend

R. Galbusera

N. Fluder

L. Enz

G. Disanto

T. Dequesne

N. Deglon

L. de Longprez

J. Damoiseaux

D. Comte

A.S. Clottu

E. Brouillet

C. Blatti

R. Bernard-Valnet

P. Benkert

T. Beltraminelli

F. Bellanger

M. Bach Cuadra

M. Absinta

Date

Source

Serveur académique Lausannois (12)

Mot-clé

Patients (9) Patients (9) Multiple sclerosis (7) Expression (7) Treatment (6) Human beings (6) Cells (6) Blood (5) modèle (4) gène (4) maladie (4) adulte (4) T cells (4) Example (4) adulte (4) maladie (4) protéine (3) Phenotype (3) Serum (3) Months (3) Memory (3) Immune response (3) Ethanes (3) Addition (3) Receptors (3) virus (2) risque (2) infection (2) analyse (2) effet (2)

Documents écrit par A. Mathias (12) | parle de A. Mathias (6)

Ocrelizumab Impairs the Phenotype and Function of Memory CD8+ T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis.

A. Mathias et al.

Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study.

C.O. Renaud et al. (21 mai 2022)

SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus.

M. Humbel et al. (2022)

Differentiation of functional astrocytes from human-induced pluripotent stem cells in chemically defined media.

S. Perriot et al. (17 déc. 2021)

Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis.

P. Maggi et al. (10 août 2021)

Advancing human induced pluripotent stem cell-derived blood-brain barrier models for studying immune cell interactions.

H. Nishihara et al.

Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.

L. Rolf et al.

Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate.

A. Mathias et al.

The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes.

N. Merienne et al. (19 sept. 2017)

EBI2 Expression and Function: Robust in Memory Lymphocytes and Increased by Natalizumab in Multiple Sclerosis.

A.S. Clottu et al. (3 janv. 2017)

The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.

A. Mathias et al. (2016)

Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.

G. Perriard et al. (2015)